manilatimes10h
AIM Vaccine mRNA RSV Vaccine Submits for Clinical Trials in the U.S.
In preclinical animal trials, third-party testing results showed that AIM Vaccine's mRNA RSV vaccine achieved significantly ...
GSK, Pfizer sales of RSV shots slow as vaccination rates ebb
Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their ...
Scientific American2d
How Bad Are COVID, Flu and RSV This Winter?
During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...
dermatologyadvisor21h
FDA Alert: Pulmonology Drug Approvals, Recalls, and Device Updates
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
Inhalon launches human challenge trial for RSV treatment
US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...
Daily Mail6d
Vaccine safety alert: Jab rolled out to millions 'could cause neurological illness', health chiefs warn
In the US Food and Drug Administration (FDA) study, officials combed through vaccine reaction data on two RSV jabs, called Abrysvo and Arexvy, documented between May 2023 and July last year.
Jab given to Brits 'could cause serious neurological condition', health experts warn
A jab given to patients to battle RSV through the NHS could potentially cause a disabling condition known as Guillain-Barré ...
The Courier-Mail6d
RSV vaccines are available for vulnerable adults and the ill. They just can’t afford them.
Two RSV vaccines were approved for use in Australia last year by the Therapeutic Goods Administration. The Australian Government is funding Pfizer’s Abrysvo for pregnant women and, in an unusual ...